NCT06068309Completed
Efficacy of CareAide® App in Improving Adherence in Adults With Chronic Diseases
Perception, Adherence, Clinical, Economical and Health-Related Quality of Life Outcomes of CareAide® App Usage in Chronic Diseases
Source: ClinicalTrials.gov · Last updated 19 Sept 2024
Brief summary (registry, in English)
The goal of this clinical trial is to study the impact of a medication adherence app, CareAide, in adult population diagnosed with chronic diseases in Malaysian population. The main question\[s\] it aims to answer are: 1. Can CareAide make people take their medications better and improve their health? 2. Can CareAide improve the health of people with chronic diseases? 3. Does using CareAide make people's lives better? 4. Can CareAide save money when managing chronic diseases? 5. How do people feel about using CareAide? Researchers will ask the participants to use the CareAide app for 6 months and compare the group that used the app with the other group which just received the usual treatment. Researchers will check if they do better with their medications, feel healthier, have a better life, and spend less money. They will check this twice, once after 3 months and again after 6 months. adherence, clinical outcomes, quality of life and economic associated with the app with two follow ups at 3 month intervals.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 900 (actual)
- First submitted
- 19 Sept 2023
- Start date
- 30 Jul 2022
- Primary completion date
- 30 Jun 2024
- Lead sponsor
- University of Malaya
- Diseases
- Heart failure, Asthma, High blood pressure
- NCT number
- NCT06068309
What you commit to
- Study type: Interventional
- Participants enrolled: 900
- From 30 Jul 2022 to the primary completion date, 30 Jun 2024
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Medications prescribed from other institution providers
- Existing mobile health app or medication reminder app user
Other illness
- Severe diseases/comorbidities - terminal cancer, psychiatry, etc
Other
- Pregnant
- Cognitively impaired
- Prisoners
- Bed-bound
Who the study is looking for
- Age: 18 years and above
- Diagnosed with selected non-communicable diseases (NCDs): hypertension, diabetes mellitus, heart failure or asthma for at least 6 months
- Prescription generated from one of the following specialty clinics: Medical, Cardiology, Diabetes Mellitus or Asthma clinics of study site.
- Medications are prescribed in previous 3 months and refill at the point of recruitment
- Morisky Medication Adherence Scale (MMAS) score \< 6 (i.e. Low adherence)
- More than three medications daily or two medications with multiple dosing intervals.
- One or more hospital admissions in the prior 24 months
- Owns a smartphone
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Pulau Pinang Coordinator of this site? Confirm its status | George Town | Malaysia | Unknown status |
| University Malaya Medical Centre Coordinator of this site? Confirm its status | Kuala Lumpur | Malaysia | Unknown status |
| Hospital Putrajaya Coordinator of this site? Confirm its status | Putrajaya | Malaysia | Unknown status |
Related publications
- Effect of a pharmacist-led mHealth app on adherence, quality of life, and glycaemic control in diabetes: A multicentre RCT.Diabetes Res Clin Pract · 2026 · PMID 42543085
- Structural analysis of causal pathways between adherence, satisfaction and clinical outcomes in hypertensive patients using a mobile adherence intervention: A SEM-NCA-cIPMA approach.J Hum Hypertens · 2026 · PMID 41896646
This page is information, not medical advice. Discuss any trial with your doctor.